Extended partnership between Radiomedix INC and ITM´s subsidiary ITG for exclusive distribution of n.c.a Lutetium-177 in North ...
Houston, TX, Oct. 11, 2017 (GLOBE NEWSWIRE) -- RadioMedix Inc, a biotechnological company, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring and therapy of cancer, and ITM Isotopen Technologien München AG (ITM), a specialized …